europabio-logoeuropabio-logoeuropabio-logoeuropabio-logo
  • About us
    • Who we are
      • Governance
      • Staff
      • Vacancies
    • What we do
  • Members
    • EuropaBio Members
    • About Membership
  • How we work
    • Healthcare Biotechnology Council
      • Cell & Gene Therapies
      • Medicines For Rare Diseases And Children
      • Regulatory Efficiency
      • Biosimilars & Public Procurement
      • Data & Digital
      • Patient Bio-Forum
    • Industrial Biotechnology Council
      • Food, Feed & Nutrition
      • Circular Bioeconomy
    • National Associations Council
    • SME Platform
    • Biomanufacturing Platform
  • Activities
    • 25 Years of Innovation
    • EFIB 2022
    • European Biotech Week
  • Events
  • Newsroom
    • News & Publications
    • Library
Become a member
✕

Bon Vivant joins EuropaBio: dairy products with a lower impact on human health, animals and planet

21/09/2022
PRESS RELEASE

Bon Vivant joins EuropaBio: dairy products with a lower impact on human health, animals and planet

Brussels, 21 September 2022 – EuropaBio is pleased to announce that Bon Vivant has joined as a corporate member.

Bon Vivant is a French biotech company developing, producing and transforming milk proteins using proprietary precision fermentation technology. The milk proteins produced by Bon Vivant are 100% identical to those produced by the cows but without lactose, without cholesterol, without antibiotics and with a much lower environmental impact.

EuropaBio Director-General Dr. Claire Skentelbery commented “We are excited to welcome another member working on sustainable dairy products through biotechnology. Together, we are the future of a more sustainable and competitive food industry in Europe”.

Bon Vivant Co-Founder and CEO, Stéphane Mac Millan, added: “We cannot wait to cooperate with EuropaBio to raise awareness on what we are doing, what is precision fermentation, why this is important that we as European we embrace these technologies, why when it comes to food we cannot continue to only rely on one source of production but we need to create a mix of food production, how the regulation should evolve, what are the potential drawback and how to avoid them”.

Bon Vivant – PR

Bon Vivant joins EuropaBio


Download
2022_09_G_PR_Bon-Vivant-joins-EuropaBioDownload
Share
Alexandra Simionca
Alexandra Simionca

Related posts

17/01/2023

EuropaBio launches SME BioForum in Rare Diseases


Read more
17/01/2023

EuropaBio launches Industry Advisory Group for new Biomanufacturing Platform


Read more
16/01/2023

SwiftPharma joins EuropaBio: pioneering sustainable, scalable and affordable plant-made therapeutic proteins


Read more
19/12/2022

EuropaBio sat down with new member Association of Biotechnological Companies Bioforum, to find out how they champion biotech in central and eastern Europe


Read more

Important links

  • EuropaBio launches SME BioForum in Rare Diseases
  • EuropaBio launches Industry Advisory Group for new Biomanufacturing Platform

Categories in our Newsroom

Search by tags

  • Innovation
  • Excellence
  • Science
  • ATMPs
  • Healthcare Biotech
  • Industrial Biotech
  • Investment
  • EuropaBio
  • EFIB
  • Regulation
  • Rare Diseases
  • COVID-19
  • Members
  • Cancer
  • Patients
  • Patient BioForum
  • Gene & Cell Therapies
  • Accessibility
  • Intellectual Property
  • Pharmaceutical Strategy for Europe

Subscribe for our newsletter

Subscribe to the EuropaBio newsletter to receive the latest news and developments in the Biotech sector!


Subscribe
EuropaBio-Logo-White

EuropaBio represents corporate and associate members across sectors, plus national and regional biotechnology associations which, in turn, represent over 2600 biotech companies, 2300 out of them are SMEs.

Contact us

Extra links

Members
Staff
Privacy policy
Legal & cookies
Events
Newsroom

Become a member

Media pack

© 2023 Europabio. All Rights Reserved. Designed by EYAS
Become a member